Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-05-04
DOI
10.1038/s41417-018-0020-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retroviral replicating vector–mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity
- (2017) Kei Hiraoka et al. NEURO-ONCOLOGY
- Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model
- (2017) Leah A. Mitchell et al. NEURO-ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Myeloid-derived suppressor cells and their role in pancreatic cancer
- (2016) M Pergamo et al. CANCER GENE THERAPY
- Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
- (2016) Katsuhiko Uesaka et al. LANCET
- Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
- (2016) Anne M Noonan et al. MOLECULAR THERAPY
- Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
- (2016) Timothy F. Cloughesy et al. Science Translational Medicine
- Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types
- (2016) Chris G. Twitty et al. Human Gene Therapy Methods
- Gene and cell therapy for pancreatic cancer
- (2015) Hans Martin Singh et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Intravenous Administration of Retroviral Replicating Vector, Toca 511, Demonstrates Therapeutic Efficacy in Orthotopic Immune-Competent Mouse Glioma Model
- (2015) Tiffany T. Huang et al. HUMAN GENE THERAPY
- Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells
- (2015) Svetlana Karakhanova et al. OncoImmunology
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- MicroRNA 142-3p Attenuates Spread of Replicating Retroviral Vector in Hematopoietic Lineage-Derived Cells While Maintaining an Antiviral Immune Response
- (2014) Amy H. Lin et al. HUMAN GENE THERAPY
- Combined Alloreactive CTL Cellular Therapy with Prodrug Activator Gene Therapy in a Model of Breast Cancer Metastatic to the Brain
- (2013) M. J. Hickey et al. CLINICAL CANCER RESEARCH
- Randomized Phase III Multi-Institutional Study of TNFerade Biologic With Fluorouracil and Radiotherapy for Locally Advanced Pancreatic Cancer: Final Results
- (2013) Joseph M. Herman et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
- (2013) Hideki Ueno et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene therapy clinical trials worldwide to 2012 - an update
- (2013) Samantha L. Ginn et al. JOURNAL OF GENE MEDICINE
- Is cancer gene therapy an empty suit?
- (2013) Malcolm K Brenner et al. LANCET ONCOLOGY
- Advanced-stage pancreatic cancer: therapy options
- (2013) Jens Werner et al. Nature Reviews Clinical Oncology
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined radiochemotherapy in patients with locally advanced pancreatic cancer: A meta-analysis
- (2013) Yue Chen WORLD JOURNAL OF GASTROENTEROLOGY
- EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study
- (2012) J. Randolph Hecht et al. GASTROINTESTINAL ENDOSCOPY
- Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression
- (2012) Omar D Perez et al. MOLECULAR THERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial
- (2011) William F. Regine et al. ANNALS OF SURGICAL ONCOLOGY
- Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
- (2011) D. Ostertag et al. NEURO-ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene
- (2010) C-K Tai et al. CANCER GENE THERAPY
- A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer
- (2010) A Nakao et al. CANCER GENE THERAPY
- Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
- (2010) John P. Neoptolemos et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HIV and SIV infection: the role of cellular restriction and immune responses in viral replication and pathogenesis
- (2009) KENNETH C. WILLIAMS et al. APMIS
- Mouse APOBEC3 Restricts Friend Leukemia Virus Infection and Pathogenesis In Vivo
- (2008) E. Takeda et al. JOURNAL OF VIROLOGY
- Host factors involved in resistance to retroviral infection
- (2008) Hiroaki Takeuchi et al. MICROBIOLOGY AND IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search